Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03149718 · ClinicalTrials.gov registry record · NA
Community Pharmacists and Opioid Misuse
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT03149718: Completed NA study, sponsored by University of Utah.
NCT03149718 is a NA study that has completed, run by University of Utah. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03149718, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Opioid medication misuse and overdose have reached epidemic proportions in the US. Community pharmacy is a potentially valuable resource for addressing opioid medication misuse. This study will manualize and establish the feasibility, acceptability, and clinical effect of a community pharmacist-led intervention aimed at: improving opioid mediation regimen adherence, eliminating misuse, connecting patients to additional care, and safeguarding against overdose.
Primary Outcome
Intervention feasibility will be established through delivery of all BI-MTM components to 85% of BI-MTM recipients.
Interventions
- BEHAVIORAL Brief Intervention Medication Therapy Management
- BEHAVIORAL Standard Medication Counseling (SMC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
What the finished NCT03149718 record still lists
NCT03149718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Brief Intervention Medication Therapy Management is the first listed.
NCT03149718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03149718 about?
NCT03149718 is a clinical study titled "Community Pharmacists and Opioid Misuse". Opioid medication misuse and overdose have reached epidemic proportions in the US. Community pharmacy is a potentially valuable resource for addressing opioid medication misuse. This study will manualize and establish the feasibility, acceptability, and clinical effect of a community pharmacist-led ...
What is the current status of trial NCT03149718?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2017-09-15. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03149718?
The interventions under investigation include: Brief Intervention Medication Therapy Management (BEHAVIORAL), Standard Medication Counseling (SMC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03149718?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03149718's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI